PLAINSBORO, N.J., Sept. 16, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NasdaqGS:IART - News) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market the DuraGen XS(TM) Dural Regeneration Matrix in the United States.
